Trial
NCT02143050
Study of Dabrafenib, Trametinib and Metformin for Melanoma Patients
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Louisville
Collaborators
James Graham Brown Cancer Center
Condition
Melanoma
Intervention
Dabrafenib
Why stopped
No participant enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-11-18